Cannaisseur Group Inc. (TCRG): Operating Income

Annual figures by period end, from SEC filings.

-$1.72M
Year ended 2025-12-31
-$989.0K
Trailing 12 months to 2026-06-30
2022-12-31: -$91.9K2023-12-31: -$189.9K2024-12-31: -$1.27M2025-12-31: -$1.72M-$1.72M
2022-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$1.72Mn/m2026-03-23, From 2025-01-01
2024-12-31-$1.27Mn/m2026-03-23, From 2024-01-01
2023-12-31-$189.9Kn/m2025-03-21, From 2023-01-01
2022-12-31-$91.9Kn/a2024-04-15, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Cannaisseur Group Inc. (TCRG)2025-12-31-$1.72Mn/m
Cyanotech Corp (CYAN)2025-03-31-$2.51Mn/m
Natural Alternatives International Inc (NAII)2026-06-30-$18.75Mn/m
C21 Investments Inc. (CWLXF)2026-03-31$2.28M+77.8%
USANA Health Sciences Inc (USNA)2026-01-03$37.43M-43.6%
Mannatech Inc (MTEX)2025-12-31-$426.0Kn/m
Nutra Pharma Corp (NPHC)2025-12-31-$1.46Mn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31-$2.17Mn/m
Adia Med, Inc. (ADIA)2025-12-31-$366.5Kn/m

Compare TCRG, CYAN, NAII, CWLXF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗